| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Stoke Therapeutics, Inc. | GENERAL COUNSEL & CORP SEC | Restricted Stock Units | 24K | $379K | $15.78 | Mar 27, 2024 | Direct |
| Stoke Therapeutics, Inc. | GENERAL COUNSEL & CORP SEC | Common Stock | 2.6K | $39.1K | $15.04 | May 20, 2024 | Direct |
| Stoke Therapeutics, Inc. | GENERAL COUNSEL & CORP SEC | Stock Option (Right to Buy) | 25.8K | May 20, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| STOK | Stoke Therapeutics, Inc. | May 20, 2024 | 3 | -$68.5K | 4 | May 22, 2024 | GENERAL COUNSEL & CORP SEC |
| STOK | Stoke Therapeutics, Inc. | Mar 28, 2024 | 2 | -$67.7K | 4 | Apr 1, 2024 | GENERAL COUNSEL & CORP SEC |
| STOK | Stoke Therapeutics, Inc. | Mar 27, 2024 | 2 | $0 | 4 | Jun 7, 2024 | GENERAL COUNSEL & CORP SEC |
| STOK | Stoke Therapeutics, Inc. | Mar 15, 2024 | 3 | -$14.3K | 4 | Mar 19, 2024 | GENERAL COUNSEL & CORP SEC |
| STOK | Stoke Therapeutics, Inc. | Dec 1, 2023 | 3 | $0 | 4 | Dec 5, 2023 | General Counsel & Corp Sec |
| STOK | Stoke Therapeutics, Inc. | Jun 21, 2023 | 1 | -$26.3K | 4 | Jun 23, 2023 | General Counsel & Corp Sec |
| STOK | Stoke Therapeutics, Inc. | Mar 15, 2023 | 2 | $0 | 4 | Mar 17, 2023 | General Counsel & Corp Sec |
| STOK | Stoke Therapeutics, Inc. | Mar 15, 2023 | 0 | $0 | 3 | Mar 17, 2023 | General Counsel & Corp Sec |